{ "as_of": "2026-11-06", "cmr": "ca-cm-kg/TSXV/TTI", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Thiogenesis Therapeutics, Corp. (TSXV: TTI) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nThiogenesis Therapeutics, Corp. is listed on the TSXV under ticker TTI, with ISIN CA88410L1022 and LEI 9845006CBA639FFD6454. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Ontario (CA-ON). The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 7 filings in the window 2025-11-06 to 2026-11-06, on 7 filing days, of which 1 is an exchange bulletin and 6 are newswire releases. The median gap between filing days is 51.5 days. The latest filing is dated 2026-10-29, a newswire release, 8 days before the record date of 2026-11-06. The TSXV exchange median is 9 filings, a 19-day cadence gap and 17.0 days of latency across 1427 issuers. The Life Sciences sector median is 7.0 filings, a 17.5-day cadence gap and 14 days of latency across 200 issuers.\n\n## Auditor\n\nThe auditor is not on the record (none found), and its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag reads listed, not halted.\n\n## Orderability\n\nUnder the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, as of the chapter date 2026-11-04, the outcome for Paragraph (o) of the definition is signal ACM-200 and determinable. The outcome for Paragraph (q) of the definition is signal ACM-200 and determinable.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations page; the coverage state is none found, with a count of 0.\n\n## Open research\n\nNo openly published research notes were found; the open research state is none found, with a count of 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer has no sealed years on the record. The market's vintage is not sealed, and the market's earliest sealed date is not on the record. The live record began 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.tsx.com/json/company-directory/search/tsxv/^* (identity.exchange)\n- https://www.marketscreener.com/quote/stock/THIOGENESIS-THERAPEUTICS--136548345 (identity.isin)\n- https://api.gleif.org/api/v1/lei-records/9845006CBA639FFD6454 (identity.jurisdiction)\n- https://www.tsx.com/en/resource/571 (identity.sector)\n- https://mcp.ca-cm-kg.ai/events/TSXV/TTI (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/TSXV/TTI (the record)\n", "market": "CA", "node": "ca-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-10", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "market": "CA", "reason": "none found", "state": "not_on_record" }, "auditor_firm_id": { "market": "CA", "state": "not_on_record" }, "auditor_location": { "market": "CA", "state": "not_on_record" }, "changes": [] }, "cmr": "ca-cm-kg/TSXV/TTI", "coverage": { "count": 0, "houses": [], "pages_checked": [], "read_by": "Perplexity sonar (search) · page read by this rail", "read_date": "2026-11-12", "since": null, "state": "none_found" }, "disclosure": { "against": { "exchange": { "issuers": 1427, "median_cadence_gap_days": 19, "median_filings": 9, "median_latency_days": 17, "name": "TSXV" }, "sector": { "issuers": 200, "median_cadence_gap_days": 17.5, "median_filings": 7, "median_latency_days": 14, "name": "Life Sciences" } }, "by_type": { "exchange_bulletin": 1, "newswire_release": 6 }, "cadence_median_gap_days": 51.5, "filing_days": 7, "filings": 7, "latency_days": 8, "latest": [ { "category": null, "date": "2026-10-29", "source": "https://www.newsfilecorp.com/release/320172/Thiogenesis-Announces-FDA-Clearance-of-IND-for-Nephropathic-Cystinosis", "title": "Thiogenesis Announces FDA Clearance of IND for Nephropathic Cystinosis", "type": "newswire_release" }, { "category": null, "date": "2026-10-22", "source": "https://www.newsfilecorp.com/release/320172/Thiogenesis-Announces-FDA-Clearance-of-IND-for-Nephropathic-Cystinosis", "title": "Thiogenesis Announces FDA Clearance of IND for Nephropathic Cystinosis", "type": "newswire_release" }, { "category": null, "date": "2026-06-08", "source": "http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=318612&CORRECTION_FLG=N&HC_FLAG1=checked", "title": "TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)", "type": "exchange_bulletin" }, { "category": null, "date": "2026-04-16", "source": "https://www.newsfilecorp.com/release/292731/Thiogenesis-Therapeutics-to-Present-at-2026-Bloom-Burton-Co.-Healthcare-Investor-Conference", "title": "Thiogenesis Therapeutics to Present at 2026 Bloom Burton & Co ...", "type": "newswire_release" }, { "category": null, "date": "2026-02-02", "source": "https://www.newsfilecorp.com/release/282105/Thiogenesis-Therapeutics-Announces-InvestigatorInitiated-Study-in-Nephropathic-Cystinosis-and-Provides-Program-Update", "title": "Thiogenesis Therapeutics Announces Investigator-Initiated Study in Nephropathic Cystinosis and Provides Program Update", "type": "newswire_release" } ], "latest_filing_date": "2026-10-29", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.ca-cm-kg.ai/events/TSXV/TTI", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*", "state": "sourced", "value": "TSXV" }, "isin": { "read_by": "Tavily search + regex extraction from page text", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.marketscreener.com/quote/stock/THIOGENESIS-THERAPEUTICS--136548345", "state": "confirmed", "value": "CA88410L1022" }, "jurisdiction": { "read_by": "GLEIF LEI record (LEI per the LEI column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://api.gleif.org/api/v1/lei-records/9845006CBA639FFD6454", "state": "sourced", "value": "Ontario (CA-ON)" }, "lei": { "read_by": "GLEIF name-exact", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://api.gleif.org/api/v1/lei-records/9845006CBA639FFD6454", "state": "filled", "value": "9845006CBA639FFD6454" }, "name": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*", "state": "sourced", "value": "Thiogenesis Therapeutics, Corp." }, "sector": { "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)", "state": "sourced", "value": "Life Sciences" }, "security_type": { "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)", "state": "sourced", "value": "Corporate" }, "segment": { "market": "CA", "state": "not_on_record" }, "ticker": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*", "state": "sourced", "value": "TTI" }, "website": { "market": "CA", "state": "not_on_record" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": [], "domicile_change": [], "listing": [], "name_change": [], "segment_move": [] }, "market": "CA", "node": "ca-cm-kg", "numbers_hash": "sha256:a347ab80bd93b207c9b99e6d8097037e40740e1c0ecdfc569758c1ef50ecbf2c", "open_research": { "read_date": "2026-11-12", "rows": [], "state": "none_found" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "Paragraph (o) of the definition", "Paragraph (q) of the definition" ], "outcomes": { "Paragraph (o) of the definition": { "determinable": true, "signal": "ACM-200" }, "Paragraph (q) of the definition": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json", "door": "https://mcp.ca-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1", "section": "ca.aio.v11" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.ca-cm-kg.ai/record/TSXV/TTI", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-08", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100", "value": "listed, not halted" } }, "numbers_hash": "sha256:a347ab80bd93b207c9b99e6d8097037e40740e1c0ecdfc569758c1ef50ecbf2c", "path": "/ca/TSXV/TTI", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "Thiogenesis Therapeutics, Corp. is listed on the TSXV under ticker TTI, with ISIN CA88410L1022 and LEI 9845006CBA639FFD6454. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Ontario (CA-ON). The listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 7 filings in the window 2025-11-06 to 2026-11-06, on 7 filing days, of which 1 is an exchange bulletin and 6 are newswire releases. The median gap between filing days is 51.5 days. The latest filing is dated 2026-10-29, a newswire release, 8 days before the record date of 2026-11-06. The TSXV exchange median is 9 filings, a 19-day cadence gap and 17.0 days of latency across 1427 issuers. The Life Sciences sector median is 7.0 filings, a 17.5-day cadence gap and 14 days of latency across 200 issuers.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor is not on the record (none found), and its location is not on the record. The record holds no auditor changes.", "title": "Auditor" }, { "id": "events", "text": "The record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag reads listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "Under the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, as of the chapter date 2026-11-04, the outcome for Paragraph (o) of the definition is signal ACM-200 and determinable. The outcome for Paragraph (q) of the definition is signal ACM-200 and determinable.", "title": "Orderability" }, { "id": "coverage", "text": "No research houses were found on the issuer's investor-relations page; the coverage state is none found, with a count of 0.", "title": "Coverage" }, { "id": "open_research", "text": "No openly published research notes were found; the open research state is none found, with a count of 0.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The issuer has no sealed years on the record. The market's vintage is not sealed, and the market's earliest sealed date is not on the record. The live record began 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.", "title": "As-of depth" }, { "id": "sources", "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://www.tsx.com/json/company-directory/search/tsxv/^*" }, { "for": "identity.isin", "source": "https://www.marketscreener.com/quote/stock/THIOGENESIS-THERAPEUTICS--136548345" }, { "for": "identity.jurisdiction", "source": "https://api.gleif.org/api/v1/lei-records/9845006CBA639FFD6454" }, { "for": "identity.sector", "source": "https://www.tsx.com/en/resource/571" }, { "for": "the disclosure lines", "source": "https://mcp.ca-cm-kg.ai/events/TSXV/TTI" }, { "for": "the halt flag", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100" }, { "for": "the orderability chapter", "source": "https://mcp.ca-cm-kg.ai/book/aio.json" }, { "for": "the record", "source": "https://mcp.ca-cm-kg.ai/record/TSXV/TTI" } ], "title": "Thiogenesis Therapeutics, Corp. (TTI) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }